INS and diabetes mellitus: Mitochondrial DNA damage remained associated with diabetes mellitus and atherosclerosis in models including cardiovascular and antidiabetic therapies (ACE inhibitor or ARB therapy, β-blocker therapy, lipid lowering therapy, antiplatelet therapy, insulin therapy, metformin therapy, or sulfonylureas) as potential covariates.